Urinary Methylcitrate (Methylcitrate)
Abnormal condensation metabolite formed by citrate synthase from oxaloacetate and accumulated propionyl-CoA.
Standard vs. Optimal Reference Rangesug/mg Cr
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<1.0 ug/mg Cr
General reference distribution across unselected commercial populations.
Undetectable (<0.5 ug/mg Cr)
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Formed in mitochondria when propionyl-CoA carboxylase or methylmalonyl-CoA mutase is deficient, preventing entry into the TCA cycle.
Differential Diagnosis
Elevated Levels (Methylcitrate High)
- •Propionic Acidemia (PCC deficiency)
- •Methylmalonic Acidemia (MUT deficiency or cobalamin defects)
- •Multiple carboxylase deficiency (holocarboxylase / biotinidase)
Low Levels (Methylcitrate Low)
- •Normal branched-chain and odd-chain fatty acid catabolism
- •Optimal metabolic therapy
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Methylcitrate
- Targeted organ system imaging or functional dynamic testing related to propionyl-coa condensation intermediate
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Urinary Methylcitrate - The New England Journal of Medicine (2021). PMID: 34090124
- [2]Methylcitrate Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Urinary Methylcitrate (Methylcitrate) into overall healthspan optimization.